Daria Tsygankova

Mrs. Daria Tsygankova


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 November 2022 in Journal of Translational Medicine
Verified
Journal Article
Open access
PDF file
EBEvgeny Bazdyrev
Evgeny Bazdyrev
MPMaria Panova
Maria Panova
MBMaria Brachs
Maria Brachs
ESElena Smolyarchuk
Elena Smolyarchuk
DTDaria Tsygankova
Daria Tsygankova
Fedor NovikovFedor Novikov
Fedor Novikov
Background: Many patients who recovered from COVID are still suffering from pulmonary dysfunction that can be persistent even for months after infection. Therefore, treatment to prevent irreversible impairment of lung function is needed. Treamid (bisamide derivative of dicarboxylic acid, BDDA) was shown to have anti-inflammatory and antifibrotic effects in animal models of pulmonary fibrosis. This study was designed to assess the safety, tolerability, and efficacy of Treamid in the rehabilitation of patients after COVID pneumonia. The aim was to establish whether Treamid could be effective in ameliorating post-COVID sequelae. Methods: The phase 2, randomized, double-blind, placebo-controlled clinical trial was done at 8 medical centers in Russia. Patients with a diagnosis of COVID in the past medical history (with the first symptoms of COVID appear no earlier than 2 months before screening) and having fibrotic changes in the lungs, decreased lung function (percentage of predicted FVC and/or DLCO < 80%), and moderate or severe dyspnea according to mMRC scale were enrolled and randomly assigned in a 1:1 ratio (stratified by the initial degree of lung damage, age, and concomitant chronic diseases) by use of interactive responsive technology to peroral administration of Treamid 50 mg or placebo once a day for 4 weeks. The primary outcome was the proportion of patients who achieved clinically significant improvement in FVC and/or DLCO (defined as a relative increase in FVC of ≥ 10% or a relative increase in FVC in the range of ≥ 5 to < 10% plus a relative increase in DLCO of ≥ 15%) at week 4 compared with baseline. Secondary endpoints included changes from baseline in dyspnea scoring evaluated by the modified Borg and mMRC scales, pulmonary function (FEV1, FVC, FEV1/FVC ratio, DLCO, TLC, FRC), 6-min walk distance, the overall score of the KBILD questionnaire, and the proportion of patients with a reduction in the degree of lung damage assessed by CT scores. This trial was registered on ClinicalTrials.gov (Identifier: NCT04527354). The study was fully funded by PHARMENTERPRISES LLC. Results: 12 out of 29 patients (41%) in Treamid group achieved clinically significant improvement in FVC and/or DLCO compared to 5 out of 30 patients (17%) in placebo group (p = 0.036). There was a significant decrease of dyspnea according to modified Borg scale observed in the Treamid group (− 0.9 ± 0.7 vs. − 0.4 ± 0.8, p = 0.018). No significant differences in the adverse events were noted. Exploratory analysis of the female population indicated superiority of Treamid over placebo by decreasing dyspnea and the extent of lung damage as well as increasing TLC. Conclusions: 4 weeks oral administration of 50 mg Treamid was associated with clinically significant improvement in the post-COVID patients, evident by an increase in FVC and/or DLCO as well as decreasing dyspnea. Treamid was well tolerated and can be safely administered to patients discharged after COVID. Treamid was more effective in women visible by superior improvement of COVID sequalae after 4 weeks treatment. Considering that female gender is a risk factor associated with the development of post-COVID symptoms, Treamid might offer a pharmacological treatment for long-term sequalae after COVID and supports further investigation in future clinical trials in post-COVID patients.

18 October 2022 in Ekologiya cheloveka (Human Ecology)
Verified
Journal Article
Open access
PDF file
ONOlga Nakhratova
Olga Nakhratova
DTDaria Tsygankova
Daria Tsygankova
EBEvgeny Bazdyrev
Evgeny Bazdyrev
DCD. P Cygankova
D. P Cygankova
DTDaria Tsygankova
Daria Tsygankova
This review analyzes the current understanding of the relationship between air pollutants and the development of general and cardiovascular mortality. Data from studies highlighting the effects of long- and short-term exposure to particulate matter on the risk of myocardial infarction, stroke, arterial hypertension, heart failure, cardiac arrhythmias, sudden death, pulmonary embolism, and atherosclerosis, as well as on hospitalization, morbidity, and mortality from these causes are summarized. Based on a review of studies published in PubMed, Scopus, Cochrane, and Google Scholar, the current paper outlines the putative pathophysiological mechanisms by which particulate matter exposure influences the cardiovascular system (CVS), primarily represented by oxidative stress, inflammation, endothelial dysfunction, lipid metabolism disorders, autonomic dysfunction, and impaired hemostatic system. Attention is focused on the impact of short- and long-term exposure to particulate matter on the CVS. The consequences of short-term exposure include the development of myocardial infarction, an increase in the frequency of hospitalization for chronic heart failure, atrial fibrillation, an increase in mortality from stroke and the risk of sudden death, and the development of pulmonary embolism. Arterial hypertension, aggravation of coronary heart disease, chronic heart failure, development of atherosclerosis and dyslipidemia, and increased risk of mortality from coronary heart disease can be considered the consequences of long-term exposure to particulate matter. Raising awareness regarding the impact of air pollutants on the CVS has been recognized as the leading approach toward reducing mortality from cardiovascular disease.

25 December 2020 in Siberian Journal of Clinical and Experimental Medicine
Verified
Journal Article
Open access
PDF file
DTDaria Tsygankova
Daria Tsygankova
NFN. V. Fedorova
N. V. Fedorova
KKKristina Krivoshapova
Kristina Krivoshapova
Sergey MaksimovSergey Maksimov
Sergey Maksimov
EIElena Vladimirovna Indukaeva
Elena Vladimirovna Indukaeva
OBOlga Barbarash
Olga Barbarash
Purpose. To assess the frequency of detection of essential hypertension in persons aged over 60 years depending on the socio-economic risk factors.Material and Methods. A total of 582 people aged 60 to 70 years were studied. All participants were surveyed to determine the level of education, income, professional affiliation, and family composition. Statistical data processing was carried out using Statistica 6.0 software. The significance level for statistical hypothesis testing in the study was <0.05.Results and Discussion. Hypertension occurred in 87.2% of rural residents and in 84.6% of urban residents (p = 0.429). This condition was diagnosed in 82.7% of men and 86.1% of women (p = 0.339). Regression analysis showed that holding a managerial position was associated with an increase in mean systolic blood pressure (SBP) by 3.1 mmHg (p = 0.013). Formal marriage or common-law marriage was associated with an increase in mean SBP by 2.4 mmHg (p = 0.034) and diastolic blood pressure (DBP) by 2.2 mmHg (p = 0.002). Living in rural areas was associated with decreased mean DBP by 1.66 mmHg (p = 0.015). The prevalence rates of hypertension were 90.5% in widows and 73.7% in women who had never been married (p = 0.031). No statistically significant differences were found between men with different marital status; however, the maximum prevalence of hypertension was observed among divorced men; the minimum prevalence was observed among widowers.Conclusions. There was no difference in the frequency of detection of hypertension between urban and rural older adults. The highest prevalence of hypertension among women was observed in widows; the lowest prevalence was found in women who had never been married. Among men, the highest prevalence of hypertension was observed in divorced persons; the minimum prevalence was detected in widowers, but the difference was not statistically significant.

1 January 2024 in ЗДОРОВЬЕ НАСЕЛЕНИЯ И СРЕДА ОБИТАНИЯ - ЗНиСО / PUBLIC HEALTH AND LIFE ENVIRONMENT
Verified
Journal Article
Open access
PDF file
AAAlena S. Agienko
Alena S. Agienko
ISIrina L. Strokolskaya
Irina L. Strokolskaya
DTDaria Tsygankova
Daria Tsygankova
GAGalina V. Artamonova
Galina V. Artamonova
ДЦД. П. Цыганкова
Д. П. Цыганкова
Background: The need to study behavioral patterns associated with lifestyle modification is evidenced not only by the high global mortality rate from cardiovascular diseases, but also by the growing burden of cardiovascular risk factors. Our objective was to assess the dynamics of risk factors in people with different health status and the role of healthy lifestyle recommendations in lifestyle changes. Materials and methods: The first stage of the study was conducted in 2016 and included 1,600 respondents while the second was in 2019 involving 991 respondents, which were then divided into three groups by their health status: apparently healthy, those who developed an atherosclerotic cardiovascular disease (CVD) during the observation period, and those already sick (initial CVD cases). The participants were examined and surveyed for the main cardiovascular risk factors, such as blood pressure, cholesterol, including its atherogenic lipoprotein, smoking, body mass index, and past illnesses. Lifestyle modification following the receipt of healthy lifestyle recommendations was assessed by survey. Results: The most pronounced dynamics of risk factors was revealed among those who developed a CVD in the course of observation: cholesterol decreased from 5.7 to 5.2 mmol/L, p = 0.005, its atherogenic lipoprotein – from 4.3 to 3.4 mmol/L, p < 0.001, systolic blood pressure – from 144 to 128 mmHg, p < 0.001, and the body mass index – from 30.8 to 30.7 kg/m2, p = 0.255. Most patients from this group (59.3 %) received healthy lifestyle recommendations and the proportions of those who followed them and modified their lifestyle were higher than in other groups (39.0 % and 54.7 %, respectively; p < 0.001). In the group of apparently healthy individuals, lifestyle recommendations were given to 27.4 % members; yet, this group was noted for a high prevalence of lifestyle self-modification (23.8 %). Among those who already suffered from a CVD at the beginning, the proportion of patients who received healthy lifestyle recommendations was 1.5 times lower (38.3 %) compared to the group of patients who developed the disease, p < 0.001. Conclusion: Those who developed a disease during observation received recommendations for a healthy lifestyle more often and modified it, but the number of such recommendations decreased with disease duration. The decision to modify the lifestyle was more often made by those who were given lifestyle recommendations, while self-modification was less frequent.

11 June 2021 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
DTDaria Tsygankova
Daria Tsygankova
OBOlga Barbarash
Olga Barbarash
Dietary modifications are an effective method for the prevention and treatment of cardiovascular diseases and their risk factors: hypertension, hyperglycemia, obesity, dyslipidemia. Large-scale studies have shown the causal relationship between eating behavior (predominant consumption of fruits, vegetables, processed meat or trans fats) and major socially significant diseases (coronary artery disease, diabetes, cancer). Based on the data obtained, national and international dietary guidelines have been developed to prevent these diseases. However, adherence to healthy diets is still low. In this connection, many researches have suggested the influence of socioeconomic status on eating behavior. The aim of this review was to analyze and discuss the main socioeconomic determinants (income and education level, marital status) of the population’s eating behavior.

28 January 2022 in Cardiovascular Therapy and Prevention
Verified
Journal Article
Open access
PDF file
OBOlga Barbarash
Olga Barbarash
DSD. Yu. Sedykh
D. Yu. Sedykh
TPT. S. Petrova
T. S. Petrova
Vasily KashtalapVasily Kashtalap
Vasily Kashtalap
DTDaria Tsygankova
Daria Tsygankova
ДСД. Ю. Седых
Д. Ю. Седых
Rationalization of dietary behavior in patients after myocardial infarction is the subject of numerous discussions. Despite the proven preventive effect of a healthy diet and the benefits of certain foods in cardiovascular diseases, this type of intervention is still underused. The aim of this review was to analyze current approaches to modifying the nutrition of patients within the secondary prevention of myocardial infarction. For this, 903 publications from PubMed/MEDLINE database over the past 5 years were studied. The Mediterranean diet demonstrated the highest efficacy and safety in preventing athero-thrombotic events among existing dietary patterns. However, its wide reproducibility in different regions is associated with a number of limitations. Government programs to modify and support a healthy diet beyond the conventional low-cholesterol diet may be promising in secondary prevention, especially if patients are properly monitored and motivated.